PATENT CLAIM ANALYSIS

Application Number: 15895855
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-12
Patent Classification: ["514", "630000"]

Abstract:
Compounds that are PSMA ligands, pharmaceutical compositions comprising these compounds, methods for treating and detecting cancers in a subject, methods for identifying cancer cells in a sample are described herein.

Claim (Index 30):
The method of  claim 26 , wherein Y is a (PEGylated) nanoparticle that is directly or indirectly linked to B, and at least one anti-cancer agent coupled to the surface of the nanoparticle.

Metadata:
- Claim Count in Document: 26.0
- Percentile: 88.0
- Lexical Diversity: 1.25926
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14767984', '15629281', '15691407', '15623353', '12744982']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8102860602046998
- 35 USC 102 Novelty (BERT): 0.5908010255891724
- Combined Prediction Score: 0.7883375567431471
- Mean Citation Score: 351.42230600000005
- Max Citation Score: 603.68317
- Similarity Product: 396.0378318158102

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test